The Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion

NCT ID: NCT04473196

Last Updated: 2024-08-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-30

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

randomized-controlled trial looking specifically at the effect of weight bearing on the outcomes of first MTP joint fusions

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this prospective, randomized controlled trial is to determine if there are any adverse outcomes associated with immediate weight bearing as compared to non-weight bearing following first MTP joint fusion. The primary outcome measures will look at patient reported outcomes of pain and function. The secondary outcome measures will be the difference in the incidence of non-union, as well as adverse events/complications (malunion, wound complications, hardware complications, infection, stress fracture).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hallux Valgus Hallux Rigidus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Weightbearing

Immediate weightbearing after surgery

Group Type ACTIVE_COMPARATOR

weightbearing

Intervention Type OTHER

immediate weightbearing

Non weightbearing

nonweightbearing x 6 weeks post surgery

Group Type ACTIVE_COMPARATOR

weightbearing

Intervention Type OTHER

immediate weightbearing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

weightbearing

immediate weightbearing

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

nonweightbearing

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or great
* Medically fit for surgery
* Patients diagnosed with condition for which a 1st MTP joint fusion is a surgical management option based on clinical examination and radiographs
* Failed non-operative management (orthotics, bracing, Tylenol, NSAIDs, shoe-wear modification)
* Surgery is for an isolated 1st MTP fusion
* Able and willing to comply with follow up schedule and requirements
* Capable of providing informed consent

Exclusion Criteria

* Age \<18 years old
* Surgical booking is for more than just 1st MTP fusion
* Unable to comply with follow up schedule and requirements
* Unable to provide informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nova Scotia Health Authority

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark Glazebrook, MD FRCS

Role: PRINCIPAL_INVESTIGATOR

NSHA\ Dalhousie UNiversity

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nova Scotia Health Authority

Halifax, Nova Scotia, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Patricia Francis, RN

Role: CONTACT

9022250199

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Trish Francis

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Rammelt S, Panzner I, Mittlmeier T. Metatarsophalangeal Joint Fusion: Why and How? Foot Ankle Clin. 2015 Sep;20(3):465-77. doi: 10.1016/j.fcl.2015.04.008. Epub 2015 Jun 10.

Reference Type BACKGROUND
PMID: 26320560 (View on PubMed)

Wood EV, Walker CR, Hennessy MS. First metatarsophalangeal arthrodesis for hallux valgus. Foot Ankle Clin. 2014 Jun;19(2):245-58. doi: 10.1016/j.fcl.2014.02.006. Epub 2014 Mar 21.

Reference Type BACKGROUND
PMID: 24878413 (View on PubMed)

Little JB. First metatarsophalangeal joint arthrodesis in the treatment of hallux valgus. Clin Podiatr Med Surg. 2014 Apr;31(2):281-9. doi: 10.1016/j.cpm.2013.12.009. Epub 2014 Feb 26.

Reference Type BACKGROUND
PMID: 24685193 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PTC 2020-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.